| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 11, 2022 | PCRX Pacira Biosciences, Inc. | Hastings Paul J77 | Director | Sell | 533 | $56.95 | $30,354.35 | -6.9% | -0.4% | -33.7% | |
| Jul 11, 2022 | PLSH Panacea Life Sciences Holdings, Inc. | Buttorff Leslie | CEO | Buy | 7,700 | $0.28 | $2,184.49 | +0.2% | - | - | |
| Jul 11, 2022 | UTHR United Therapeutics Corp | Dwek Raymond | Director | Sell | 2,160 | $241.29 | $521,186.40 | -100% | -14.8% | -8.3% | |
| Jul 7, 2022 | ZTS Zoetis Inc. | Peck Kristin C66 | Chief Executive Officer | Sell | 311 | $180.00 | $55,980.00 | -0.8% | -13.5% | -6.3% | |
| Jul 7, 2022 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $242.04 | $1,452,237.35 | -3.8% | -11.7% | -11.8% | |
| Jul 6, 2022 | AMLX Amylyx Pharmaceuticals, Inc. | Als Invest 1 B.V. | 10% Owner | Sell | 60,609 | $20.70 | $1,254,641.82 | -0.3% | +51.3% | -0.1% | |
| Jul 6, 2022 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 177,243 | $330.28 | $58,539,295.72 | - | +0.2% | +41.2% | |
| Jul 5, 2022 | AMPH Amphastar Pharmaceuticals, Inc. | Gerst Diane G. | Director | Sell | 1,813 | $35.00 | $63,460.26 | -12.4% | -18.1% | +66.5% | |
| Jul 5, 2022 | PCRX Pacira Biosciences, Inc. | Slonin Jonathan72 | Chief Clinical Officer | Sell | 924 | $57.19 | $52,841.71 | -2.4% | -5.6% | -33.5% | |
| Jul 5, 2022 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | Director | Sell | 350,000 | $3.09 | $1,081,675.00 | -4.4% | -11.4% | -49.4% | |
| Jul 5, 2022 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 19,331 | $5.00 | $96,655.00 | -58.5% | +9.4% | +75.0% | |
| Jul 1, 2022 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $34.78 | $17,390.85 | -0.6% | -18.0% | +62.6% | |
| Jun 30, 2022 | AMPH Amphastar Pharmaceuticals, Inc. | Gerst Diane G. | Director | Sell | 5,146 | $35.00 | $180,110.00 | -28.6% | -15.7% | +65.2% | |
| Jun 30, 2022 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 18,386 | $34.95 | $642,590.70 | -15.5% | -15.7% | +65.2% | |
| Jun 30, 2022 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 8,000,000 | $0.01 | $40,000.00 | +9.7% | - | - | |
| Jun 30, 2022 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | Chief Executive Officer | Sell | 19,959 | $11.58 | $231,125.22 | -2.5% | -7.8% | -7.7% | |
| Jun 30, 2022 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 1,623 | $2.04 | $3,314.24 | +0.2% | +10.8% | -29.2% | |
| Jun 30, 2022 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 533 | $2.04 | $1,088.43 | +0.2% | +10.8% | -29.2% | |
| Jun 30, 2022 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 797 | $2.04 | $1,627.57 | +0.2% | +10.8% | -29.2% | |
| Jun 30, 2022 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 2,717 | $2.04 | $5,547.99 | - | +10.8% | -29.2% | |
| Jun 28, 2022 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 900 | $329.01 | $296,109.00 | - | -2.9% | +45.3% | |
| Jun 27, 2022 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 41,857 | $329.05 | $13,772,836.57 | - | -5.7% | +42.8% | |
| Jun 27, 2022 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 754 | $100.00 | $75,400.00 | -4.3% | +0.6% | -5.2% | |
| Jun 27, 2022 | CBSTF Cannabist Co Holdings Inc. | Goldberg Philip | - | Buy | 23,500 | $1.36 | $31,960.00 | +0.3% | - | - | |
| Jun 27, 2022 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 4,334 | $175.00 | $758,450.00 | -15.5% | -14.2% | -1.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.